Life Stem Genetics Inc.
LIFS
Other OTC0.00
USD
- -
- -
CIK
0001556377
ISIN
US53217Y1038
CUSIP
53217Y103
Return %
Stock
S&P500
1Y
0.00
19.01
3Y
-97.14
65.48
5Y
- -
72.20
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Xin Shi
- Sector
- Healthcare
- Industry
- Biotechnology
- Address
- 3300 Parker Lane East Stroudsburg PA United States of America
- IPO Date
- Oct 22, 2013
- CIK
- 0001556377
- Website
- lifestemgenetics.com
- Similar Companies
- Business
- Life Stem Genetics Inc. operates as a development-stage biotechnology company specializing in the establishment and operation of stem cell therapy-based clinics worldwide. The company offers a wide range of products and services including nutraceutical and medicinal supplements, intravenous (IV) nutritional cocktails, stem cell banking services, and stem cell treatments targeting degenerative conditions, cancer, weight loss, and anti-aging therapies. It also provides specialized therapies such as hyperbaric oxygen therapy, anti-viral treatments, and Adistem stem cell treatments for orthopedic, neurological, and lung diseases. Life Stem Genetics serves multiple healthcare segments with a primary focus on regenerative medicine and cell therapy research. The company operates primarily in the United States and globally through its clinics and strategic partnerships. Founded in 2012 and headquartered in East Stroudsburg, Pennsylvania, Life Stem Genetics has recently entered into a strategic collaborative agreement with American CryoStem Corporation to enhance its adult stem cell therapy offerings. This partnership supports patient access to advanced stem cell storage and treatment options. The company continues to expand its product and service portfolio in stem cell therapies, emphasizing innovative treatment solutions in anti-aging, anti-viral care, and degenerative disease management. Life Stem Genetics remains focused on growing its clinical operations and research capabilities within the regenerative healthcare industry, positioning itself as a developing leader in stem cell therapy applications. The company’s strategic alliances and product development efforts reflect its commitment to life sciences and regenerative medicine advances, with an operational footprint that includes stem cell banking, clinical therapies, and supplement products designed for various therapeutic uses. Its comprehensive service offerings target both wellness and medical markets, positioning Life Stem Genetics as a multifaceted provider in the stem cell therapy and healthcare facility sector. The company’s development stage status underscores ongoing efforts to scale operations and expand clinical services globally. Overall, Life Stem Genetics Inc. presents a broad portfolio of regenerative medicine services and therapeutic products, supported by recent strategic collaborations and ongoing clinic development initiatives aimed at expanding its presence in the global stem cell treatment industry.